Fusion Antibodies plc Total Liabilities

The latest total liabilities for FAB.L is $1.1M as of March 2026. That compares with $650K in the prior-year period — up 68.8% year over year. Investors often review this figure alongside Fusion Antibodies plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, FAB.L's total liabilities moved from $650K to $1.1M — a 68.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Fusion Antibodies plc's operating scale or balance-sheet position.

A total liabilities figure of $1.1M for FAB.L is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FAB.L's total liabilities ($1.1M), review year-over-year change from $650K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Fusion Antibodies plc's total liabilities against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.